Clinical outcome and side effects of concomitant chemoradiotherapy in the treatment of locally advanced inoperable non-small cell lung cancer: Our experiences
Background/Aim. About 1.8 million new lung cancer cases are diagnosed worldwide every year, and about 1.6 million cases have a fatal outcome. Despite improvements in treatment in the previous decades, the survival of patients with lung cancer is still poor. The five-year survival rate is about 50% f...
Saved in:
| Main Authors: | Radojičić Bojan, Radojičić Marija, Mišović Miroslav, Kostić Dejan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade
2022-01-01
|
| Series: | Vojnosanitetski Pregled |
| Subjects: | |
| Online Access: | http://www.doiserbia.nb.rs/img/doi/0042-8450/2022/0042-84502100038R.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Paediatric cerebellar glioblastoma - long-term survival following surgery and adjuvant chemoradiotherapy: A case report and literature review
by: Matthew I. Sanders, et al.
Published: (2024-01-01) -
Long‐Term Survival Analysis of Neoadjuvant Chemoradiotherapy Versus Adjuvant Chemoradiotherapy for Locally Advanced Low Rectal Cancer
by: Siyuan Chen, et al.
Published: (2025-08-01) -
CHEMORADIOTHERAPY FOR ORAL CANCER USING HYPERFRACTIONATED RADIATION SCHEDULE
by: M. U. Radzhapova, et al.
Published: (2021-05-01) -
Comparison of vinorelbine with cisplatin in concomitant chemoradiotherapy in head and neck carcinoma
by: Devleena, et al.
Published: (2010-03-01) -
Effect of primary tumor volume on survival of concurrent chemoradiotherapy in stage IV non‐small cell lung cancer
by: Xiaxia Chen, et al.
Published: (2024-09-01)